Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 377

The DOI matches its Crossref record.

Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study

Whitehead, Helen M., Boreham, Colin, Mcllrath, Edwin M., Sheridan, Brian, Kennedy, Laurence, Atkinson, A. Brew, Madden, David R.·1992·Clinical Endocrinology

Abstract

Summary: objective We aimed to study the effect of biosynthetlc growth hormone (GH) replacement In growth hormone deficient adults. design We performed a double‐blind placebo‐controlledcross‐over study of 6 months biosynthetic GH, replacement and 6 months placebo separated by a 1‐month'swashout period. patients Fourteen growth hormone deficient adults were studied. measurements We measured total body weight, percentage fat mass, lean body mass, muscle volume, exercise capacity, maximum oxygen consumption, muscle strength, bone mineral content, a number of biochemical parameters, IGF‐I, GH antibodies andpsychological well‐being. results Total body weight remained unchanged, but lean body mass increased (before GH mean ± SEM 49·8±5·5, after 53·4±5·6 kg; placebo before 51·2±5·4, after 50·4±5·1 kg; P < 0·05 and fat mass decreased (before GH 21·5±4·1, after 19·3±4·3, placebo before 19·3±4·0, after 22·5±4·5 kg; p < 0·05). Thigh muscle volume increased: (before GH 94·1±7·7, after 99·5±8·4 ml; placebo before 99·3±8·6, after 95·4±7·8 ml/0·8 mm computerized tomographic slice; P < 0·05). Exercise capacity increased (before GH 174·15, after 199·18·9 watts; placebo before 162·5±2·3, after 154·19·8 watts; P < 0·05), as did maximum oxygen consumption (before GH 1·93±0·2, after 2·17±0·2 I/m; placebo before 1·92±0·3, after 1·98±0·2 I/m; P < 0·05). There was no change in quadriceps muscle strength. Alkaline phosphatase increased (before GH 87·5 (32–158), after 106·0 (49–179) U/l; placebo 98·5 (50–145), after 72·0 (40–111) U/l; P < 0·05) without a change in the spinal bone density. IGF‐I increased (before GH 62 (36–97), after 216 (62–362) μ g/l; placebo before 59 (52–112), after 60·5 (38–94) μ g/l; P < 0·05). Carbohydrate tolerance remained unchanged as did fasting lipids, serum sodium, potassium, urea, calcium, phosphate and liver transaminases. Psychological well‐being remained unchanged. No growth hormone antibodies were detected before or after GH treatment. conclusions GH alters the body composition of growthhormone deficient adults and leads to improved exercisecapacity; alkaline phosphatase activity increases butwithout a change in spinal bone density, and carbohydratetolerance remains unaltered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1992.tb02901.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 377

Metadata

Authors
Whitehead, H. M., Boreham, C., Mcllrath, E. M., Sheridan, B., Kennedy, L., Atkinson, A. B., & Madden, D. R.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1992-01
Volume
36
Issue
1
Pages
45-52
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2000607618
Cited by
377
References
0
FWCI
16.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study. https://app.cochat.ai/papers/10.1111/j.1365-2265.1992.tb02901.x
The paper
Whitehead, H. M., Boreham, C., Mcllrath, E. M., Sheridan, B., Kennedy, L., Atkinson, A. B., & Madden, D. R. (1992). Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1992.tb02901.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.